Octagon Therapeutics, Inc.
Glycoprotein-targeting therapeutics for autoimmune and inflammatory diseases
- Sector
- Biotech
- Headquarters
- PROVIDENCE, RI
- Founded
- 2016
- Latest Form D
- $11M, Feb 2024
- Total capital
- $12.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $12.4M
- 4 Form D · last Feb 2024
- 32 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 19 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$11M
- Private capital raisedForm D · SEC · 3rd filing$398K
- Private capital raisedForm D · SEC · 2nd filing$511K
- Private capital raisedForm D · SEC · 1st filing$538K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Fred AusubelExecutive Officer, DirectorNamed in SEC Form D filings
- Isaac StonerExecutive Officer, DirectorNamed in SEC Form D filings
- Paul GoldenheimDirectorNamed in SEC Form D filings
- Ronald LennoxDirectorNamed in SEC Form D filings
- Shen YuExecutive Officer, DirectorNamed in SEC Form D filings
- Thorne SparkmanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 19- PendingTreatment And Diagnosis Of Immune Disorders Relating To Aberrant Immune CellsUSPTOApplication 18294879
- PendingCancer Cell ModulatorsUSPTOApplication 18014856
- PendingImmune Cell ModulatorsUSPTOApplication 17800055
Show all 19 patent records
- Treatment And Diagnosis Of Immune Disorders Relating To Aberrant Immune CellsOct 24, 2024 · Application 18294879Pending
- Cancer Cell ModulatorsOct 12, 2023 · Application 18014856Pending
- Immune Cell ModulatorsApr 20, 2023 · Application 17800055Pending
- Modulation Of Immune CellsApr 20, 2023 · Application 17759775Pending
- Pre-Activated Nucleoside IMPDH Inhibitors As Anti-Infective DrugsNov 18, 2021 · Application 17282526Pending
- Cancer Cell ModulatorsApplication PCTUS2021015845Pending
- Modulation Of Immune CellsApplication PCTUS2021015891Pending
- Immune Cell ModulatorsApplication PCTUS2021015846Pending
- Cancer Cell ModulatorsApplication 63049278Pending
- Immune Cell ModulatorsApplication 63004922Pending
- Immune Cell ModulatorsApplication 62978003Pending
- Modulation Of Immune CellsApplication 62969530Pending
- Modulation Of Immune CellsApplication 62968667Pending
- Binding Agents For Treatment Of Autoimmune ConditionsApplication PCTUS2024019936Pending
- Pre-activated Nucleoside Impdh Inhibitors As Anti-infective DrugsApplication PCTUS2019054742Pending
- Detection And Treatment Of Immune ConditionsApplication PCTUS2024012644Pending
- Binding Agents For Treatment Of Autoimmune ConditionsApplication 63490459Pending
- Detection And Treatment Of Immune ConditionsApplication 63440577Pending
- Treatment And Diagnosis Of Immune Disorders Relating To Aberrant Immune CellsApplication PCTUS2021044638Pending
Related companies, and why
- Morphoceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Genprex, Inc.Similar federal contract value in Biotech · null in contracts
- Convelo Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- nferenceSimilar federal contract value in Biotech · null in contracts
- HDL THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Encellin, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .